S. No.

ONCOLOGY INTERMEADIATES

CAS NO.

1.

IMATINIB INTERMEADIATE

N-(2-Methyl -5- Amino Phenyl) -4(3-Pyridyl) -2 Pyrimidine Amine

152460-10-1

4- (4- Methyl -1-Pirelazinyl ) Methyl Benzoic Acid Di hydro Chloride

106261-49-8

4 - (4 - Methyl -1- Piperazinyl) Methyl Benzoyl Chloride 2HCL

106261-64-7

2.

GIFTA NIB INTERMEADIATE

4 - Chloro - 6,7 - Di Methoxy Quinazoline

13790-39-1

6,7 Di Methoxy - 3,4 Di Hydro Quinazoline - 4 - one

13794-72-4

3.

ERLOTINIB INTERMEADIATE

4-Chloro-6,7 Bis-(2-Methoxy ethoxy)-4,3 CH) Quinazoline

183322-18-1

6,7-Bis -2 (Nethoxy ethoxy)-4(3H)Quinazolinone

179688-29-0

4.

PAZOPANIB INTERMEADIATE

5 Nitro - 2 - Ethyl Aniline

20191-74-6

2,3 Di methyl - 2 H - Indazole - 6 - Amine

444731-72-0

N - (2 Chloro Pyrimidin - 4 - Yl ) - N,2,3 Tri methyl - 2H - Indazol - 6 - Amine

444731-75-3

5 Amino - 2 - Methyl Benzane Sulfonamide

6973-09-7

5.

PEMETREXED DI SODIUM INTERMEADIATE

2 - Chloro - 4,6, Di Methoxy 1,3,5, triazine.

137281-23-3

6.

LETRAZOLE INTERMEADIATE

4-Bromo Methyl Benzo Nitrile.

106261-64-7

4(1,2,4)Triazole -1- yl methyl - Benzo Nitrile

112809-25-3

7.

ANASTRAZOLE INTERMEADIATE

2,2 (5 Methyl - 1,3, Phenylene) Di (2- Methyl Propionitrile

120511-73-1

2,2 (5 Bromo Methyl -1,3 - Phenylene) Di (2- Methyl Propionitrile).

8.

CAPECITABINE INTERMEADIATE

2,3 - Di - O - Acetyl - 5 -De oxy - 5 - Flouro - D - cytidine

161599-46-8

9.

PACLITAXEL,DOCETAXAL INTERMEADIATE

(4S,5R) -N- Boc - 2, 2 Di Methyl - 4 - Phenyl - 5 - Oxazolidine Carboxylic Acid

114977-28-5

10.

BENDA MUSTINE HCL INTERMEADIATE

4-{5-[Bis-(2-hydroxy-ethyl)-amino]-1-Methyl-lH Benzoimodazole-2-yl}-butyric Acid ethylester

3543-74-6

4-(5amino-1-Methyl-lH-Benzoimidazol-2-Yl)Butyric Acid ethyl ester

3543-73-5

11.

SORAFENIB INTERMEADIATE

4-(3N-Methyl carbonyl Phenoxy phenoxy)-1-Amino Benzene

4-Chloro N-Methyl 2-pyridine carboxamide

API’s

1. Keterolac tromethamine
2. Pregablin

U / Development :

1. Tapentadol
2. Dabigatran
3. Boceprevir
4. Telaprevir

Note :

Above products will not supplied to countries in which these could be in Conflict with existing patents and the above products will only be offered to the extent that they will be used to obtain marketing approval and not for any Commercial use. Final responsibility lies exclusively with the buyer.